News
Brief news reports on Tuberculosis
By
Health-e
Published: June 13, 2014, 12:36 p.m.·
Tags:
Correctional facilities
Despite court-mandated moves by government to stem the tuberculosis (TB) epidemic, a recent Treatment Action Campaign (TAC) investigation has found just eight doctors serve the Department of Correctional Services.
Read More →
By
Dr Dalene von Delft
Published: June 13, 2014, 12:22 p.m.·
Tags:
Drug-resistant TB
As a medical student, Dr Dalene von Delft contracted multidrug-resistant tuberculosis (MDR-TB). The experience has propelled her into advocacy, she writes why.
Read More →
By
US Pharmacopeial Convention
Published: June 13, 2014, 12:09 p.m.·
Tags:
Treatment,
Access,
Drug-resistant TB
Rockville, Md., June 10, 2014 — The US Pharmacopeial Convention (USP) is pleased to announce that with the assistance of the U.S. Agency for International Development (USAID) funded Promoting the Quality of Medicines (PQM) program, the first Active Pharmaceutical Ingredient (API) for injectables used in the treatment of multi-drug resistant tuberculosis has been assessed by the World Health Organization and given prequalification status. The prequalification of Capreomycin, the first “second line” anti-tuberculosis API for injectables to achieve this status, is a significant development in the global fight against one of the world’s most prevalent and deadly diseases.
Read More →
By
June Greist
Published: June 12, 2014, 7:02 p.m.·
Tags:
Diabetes
Research at Colorado State University has revealed new links between tuberculosis and diabetes, providing evidence that TB becomes more deadly when it occurs with diabetes and showing for the first time that tuberculosis can actually trigger pre-diabetes.
Read More →
By
Wilma Stassen
Published: June 12, 2014, 6:53 p.m.·
Tags:
Diagnostics,
Drug-resistant TB,
HIV coinfection
The Department of Health’s multi-million rand investment in an automated, rapid TB test is being short-changed by slow health systems, said researchers this week.
Read More →
By
Julia Fraser
Published: June 6, 2014, 9:58 p.m.·
Tags:
Advocacy
The Fight the Fakes campaign announced today the support of the Generic Pharmaceutical Association and 10 other new partners for its campaign to raise awareness worldwide about the dangers of fake medicines.
Read More →
By
Stop TB Partnership
Published: June 6, 2014, 8:08 p.m.·
Tags:
Treatment,
Drug-susceptible TB,
HIV coinfection
6, June 2014 – Geneva – The Stop TB Partnership Global Drug Facility (GDF) has achieved a near 60% reduction in the price of Rifabutin, by including a new supplier into its product catalogue.
Read More →
By
Kim Cloete
Published: June 6, 2014, 7:36 p.m.·
Tags:
Treatment,
Drug-resistant TB,
Pediatrics
Experts are concerned that we’re running into an era where we don’t have drugs available because organisms have developed resistance to these drugs.
Read More →
By
TuBerculosis Vaccine Initiative (TBVI)
Published: June 6, 2014, 7:31 p.m.·
Tags:
Vaccines,
Scientific research
The tuberculosis vaccine candidate MTBVAC is the only vaccine in clinical trials based on an attenuated Mycobacterium tuberculosis strain of human origin. In various animal models, MTBVAC confers a similar attenuation and greater immunity than the current BCG vaccine against tuberculosis. BCG is a Mycobacterium bovis derivative, isolated from cows in the early twentieth century, which does not protect against respiratory forms of tuberculosis. MTBVAC is developed by TBVI’s research partner University of Zaragoza in collaboration with biopharmaceutical company Biofabri.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: June 6, 2014, 7:28 p.m.·
Tags:
Global TB response
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Read More →
Page 636 of 878 · Total posts: 10
←First
635
636
637
Last→